Related Experiment Video
Updated: Jun 7, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Structure-function relationship of dynorphin B variants using naturally occurring amino acid substitutions
Luca Zangrandi1,2, Barbara Fogli1, Anna Mutti1
1Institute of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
Researchers developed novel dynorphin B (DynB) variants with enhanced selectivity for kappa opioid receptors (KOPrs). These DynB derivatives show potential for targeted therapeutic effects by minimizing unwanted interactions with other opioid receptors.
Area of Science:
- Pharmacology and Medicinal Chemistry
- Neuroscience
- Molecular Biology
Background:
- Dynorphins (Dyn) are endogenous opioid peptides with high affinity for kappa opioid receptors (KOPrs), mediating anticonvulsant effects.
- Dyn also interact with mu (MOPrs) and delta opioid receptors (DOPrs), potentially leading to unwanted side effects.
- Optimizing dynorphin therapy requires enhanced KOPr selectivity and reduced mTOR pathway activation.
Purpose of the Study:
- To design and characterize dynorphin B (DynB) variants with improved selectivity for KOPrs over MOPrs and DOPrs.
- To investigate the impact of specific amino acid substitutions on opioid receptor binding affinity and signal transduction.
- To evaluate functional selectivity and mTOR pathway activation of novel DynB derivatives.
Main Methods:
- Synthesis of DynB variants with single or double amino acid substitutions.
- Competitive radio binding assays to determine receptor affinity.
- GTPγS assays, PRESTO-Tango, and Western blotting to assess G-protein and β-arrestin pathway activation and mTOR signaling.
Main Results:
- Seven DynB derivatives exhibited at least 10-fold greater selectivity for KOPrs compared to MOPrs or DOPrs.
- DynB_G3M/Q8H showed highest selectivity for KOPrs over MOPrs; DynB_L5S demonstrated highest selectivity for KOPrs over DOPrs.
- Selectivity gains resulted from reduced affinity/potency at MOPrs/DOPrs, not increased affinity at KOPrs; no DynB variants showed increased potency or functional selectivity.
Conclusions:
- Amino acid substitutions at positions 3, 5, and 8 significantly influence MOPr and DOPr binding and activation.
- Dynorphin B variants with enhanced KOPr selectivity were successfully generated.
- Receptor affinity alone is insufficient for predicting peptidergic agonist potency or efficacy; downstream pathway assessment is crucial for predicting in vivo effects.
Related Concept Videos
Opioid Receptors: Overview
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Mutations
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

